Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice

Journal of the Neurological Sciences

Volumn 306, Issue 1-2, 2011, Pages 9-15

  Kim, Susan S ^a   Richman, David P ^a   Zamvil, Scott S ^b   Agius, Mark A ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

Author keywords

B cell activating factor; BAFF receptor; Central nervous system inflammation; Experimental autoimmune encephalomyelitis; Macrophages; Multiple sclerosis; T cells

Indexed keywords

B CELL ACTIVATING FACTOR RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 6; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL COUNT; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE SEVERITY; FEMALE; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE ACTIVATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION;

ANIMALS; AUTOIMMUNITY; B-CELL ACTIVATION FACTOR RECEPTOR; CENTRAL NERVOUS SYSTEM; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; LYMPHOCYTES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; SPLEEN; STATISTICS, NONPARAMETRIC;

EID: 79958771891     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.04.008     Document Type: Conference Paper

References (22)

1. Lyons JA, Ramsbottom MJ, Cross AH. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Eur J Immunol 2002 Jul;32(7):1905-13. (Pubitemid 34814546)
2. Lassmann H, Bruck W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain pathology (Zurich, Switzerland) 2007 Apr;17(2) 210-8. (Pubitemid 46466140)
3. Weiner HL. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch Neurol 2004 Oct;61(10):1613-5. (Pubitemid 39350279)
4. Rammohan KW, Shoemaker J. Emerging multiple sclerosis oral therapies. Neurology 2010 Jan 5;74(Suppl 1):S47-53.
5. Thompson JS, Bixler SA, Qian F, Vora K, Scott ML, Cachero TG, et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 2001 Sep 14;293(5537):2108-11. (Pubitemid 32848062)
6. Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 2000 Apr 27;404(6781):995-9. (Pubitemid 30243593)
7. Nardelli B, Belvedere O, Roschke V, Moore PA, Olsen HS, Migone TS, et al. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 2001 Jan 1;97 (1):198-204. (Pubitemid 32061261)
8. Gorelik L, Gilbride K, Dobles M, Kalled SL, Zandman D, Scott ML. Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells. J Exp Med 2003 Sep 15;198(6):937-45. (Pubitemid 37152930)
9. Sasaki Y, Casola S, Kutok JL, Rajewsky K, Schmidt-Supprian M. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol 2004 Aug 15;173(4):2245-52. (Pubitemid 39063079)
10. Ng LG, Sutherland AP, Newton R, Qian F, Cachero TG, Scott ML, et al. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol 2004 Jul 15;173(2):807-17. (Pubitemid 38924255)
11. Chang SK, Arendt BK, Darce JR, Wu X, Jelinek DF. A role for BLyS in the activation of innate immune cells. Blood 2006 Oct 15;108(8):2687-94.
12. Jeon ST, Kim WJ, Lee SM, Lee MY, Park SB, Lee SH, et al. Reverse signaling through BAFF differentially regulates the expression of inflammatory mediators and cytoskeletal movements in THP-1 cells. Immunol Cell Biol 2010 Feb;88(2):148-56.
13. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003 Feb 13;421(6924):744-8. (Pubitemid 36227625)
14. Miller DJ, Hayes CE. Phenotypic and genetic characterization of a unique B lymphocyte deficiency in strain A/WySnJ mice. Eur J Immunol 1991 May;21(5):1123-30.
15. Miller DJ, Hanson KD, Carman JA, Hayes CE. A single autosomal gene defect severely limits IgG but not IgM responses in B lymphocyte-deficient A/WySnJ mice. Eur J Immunol 1992 Feb;22(2):373-9.
16. Weber MS, Prod'homme T, Youssef S, Dunn SE, Rundle CD, Lee L, et al. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat Med 2007 Aug;13(8):935-43.
17. Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M, et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001 Sep 14;293(5537):2111-4. (Pubitemid 32848063)
18. Sasaki Y, Derudder E, Hobeika E, Pelanda R, Reth M, Rajewsky K, et al. Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 2006 Jun;24(6):729-39. (Pubitemid 43867365)
19. Enzler T, Bonizzi G, Silverman GJ, Otero DC, Widhopf GF, Anzelon-Mills A, et al. Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. Immunity 2006 Sep;25(3):403-15. (Pubitemid 44354213)
20. Lee-Chang C, Lefranc D, Salleron J, Faveeuw C, Allet C, Vermersch P, et al. Susceptibility to experimental autoimmune encephalomyelitis is associated with altered B-cell subsets distribution and decreased serum BAFF levels. Immunol Lett 2011 Mar 30;135(1-2):108-17.
21. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002 Oct;3(10):944-50. (Pubitemid 35154008)
22. Weber MS, Prod'homme T, Patarroyo JC, Molnarfi N, Karnezis T, Lehmann-Horn K, et al. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann Neurol 2010 Jul 16.